Evidence map›Paper›PMID 24297048›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24.

Qinbo Zhou, Chastain Anderson, Hongmei Zhang, Xinyu Li, Fiona Inglis, Ashwath Jayagopal, Shusheng Wang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. RNA expression in human retina.Human molecular genetics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qinbo ZhouDepartment of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
Chastain AndersonDepartment of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
Hongmei ZhangDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Xinyu LiDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Fiona InglisDepartment of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
Ashwath JayagopalDepartment of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Shusheng WangDepartment of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA; Department of Ophthalmology, Tulane University, New Orleans, Louisiana, USA. Electronic address: swang1@tulane.edu.
Tulane University · USThe University of Texas Southwestern Medical Center · USVanderbilt University Medical Center · US

Funding

In Vivo Molecular Imaging of the RetinaR01EY023397 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PENN, JOHN S., UDDIN, MD IMAM · 2013 to 2022
$3.6M
Regulation of Ocular Angiogenesis by microRNAsR01EY021862 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI WANG, SHUSHENG · 2011 to 2021
$2.8M
NEI NIH HHS EY021862NEI NIH HHS R01 EY021862NEI NIH HHS R01 EY023397
6 · The paper itself

Abstract

Actin cytoskeleton is critical for cell motility and division, both of which are important for angiogenesis. MicroRNAs (miRNA/miR) are emerging as pivotal modulators of vascular development and disease. How miRNAs regulate actin cytoskeleton dynamics in endothelial cells (EC) and neovascularization is still unclear. Here, we report that miR-24 regulates actin dynamics in ECs through targeting multiple members downstream of Rho signaling, including Pak4, Limk2, and Diaph1 proteins. Overexpression of miR-24 in ECs blocks stress fiber and lamellipodia formation, represses EC migration, proliferation, and tube formation in vitro, as well as angiogenesis in an ex vivo aortic ring assay. Moreover, subretinal delivery of miR-24 mimics represses laser-induced choroidal neovascularization (CNV) in vivo. Mechanistically, knockdown of miR-24 target protein LIMK2 or PAK4 inhibits stress fiber formation and tube formation in vitro, mimicking miR-24 overexpression phenotype in angiogenesis, while overexpression of LIMK2 and PAK4 by adenoviruses partially rescued the tube formation defects in miR-24 overexpressing ECs. Taken together, these findings suggest that miR-24 represses angiogenesis by simultaneously regulating multiple components in the actin cytoskeleton pathways. Manipulation of actin cytoskeleton pathways by miR-24 may represent an attractive therapeutic solution for the treatment of wet age-related macular degeneration (AMD) and other vascular diseases.

Indexed as

Signal Transduction3' Untranslated RegionsActin CytoskeletonAnimalsBase SequenceCell LineChoroidal NeovascularizationEndothelial CellsGene Expression RegulationGene SilencingHumansLim KinasesMaleMiceMicroRNAsModels, Biological3' Untranslated RegionsLIMK2 protein, humanLim KinasesMicroRNAsMIRN24 microRNA, humanp21-Activated KinasesPAK4 protein, human

Identifiers

PMID24297048
PMCPMC3916039
OpenAlexW2088467455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.